The emergence of foundation models in healthcare has opened new avenues for learning generalizable representations from large scale clinical data. Yet, existing approaches often struggle to reconcile the tabular and event based nature of Electronic Health Records (EHRs) with the sequential priors of natural language models. This structural mismatch limits their ability to capture longitudinal dependencies across patient encounters. We introduce SerialBEHRT, a domain aligned foundation model that extends SciBERT through additional pretraining on structured EHR sequences. SerialBEHRT is designed to encode temporal and contextual relationships among clinical events, thereby producing richer patient representations. We evaluate its effectiveness on the task of antibiotic susceptibility prediction, a clinically meaningful problem in antibiotic stewardship. Through extensive benchmarking against state of the art EHR representation strategies, we demonstrate that SerialBEHRT achieves superior and more consistent performance, highlighting the importance of temporal serialization in foundation model pretraining for healthcare.

Revolutionizing drug discovery demands more than just understanding molecular interactions - it requires generative models that can design novel ligands tailored to specific biological targets. While chemical Language Models (cLMs) have made strides in learning molecular properties, most fail to incorporate target-specific insights, restricting their ability to drive de-novo ligand generation. Chem42, a cutting-edge family of generative chemical Language Models, is designed to bridge this gap. By integrating atomic-level interactions with multimodal inputs from Prot42, a complementary protein Language Model, Chem42 achieves a sophisticated cross-modal representation of molecular structures, interactions, and binding patterns. This innovative framework enables the creation of structurally valid, synthetically accessible ligands with enhanced target specificity. Evaluations across diverse protein targets confirm that Chem42 surpasses existing approaches in chemical validity, target-aware design, and predicted binding affinity. By reducing the search space of viable drug candidates, Chem42 could accelerate the drug discovery pipeline, offering a powerful generative AI tool for precision medicine. Our Chem42 models set a new benchmark in molecule property prediction, conditional molecule generation, and target-aware ligand design. The models are publicly available at huggingface.co/inceptionai.

The rapid emergence of antibiotic-resistant bacteria is recognized as a global healthcare crisis, undermining the efficacy of life-saving antibiotics. This crisis is driven by the improper and overuse of antibiotics, which escalates bacterial resistance. In response, this study explores the use of clinical decision support systems, enhanced through the integration of electronic health records (EHRs), to improve antibiotic stewardship. However, EHR systems present numerous data-level challenges, complicating the effective synthesis and utilization of data. In this work, we transform EHR data into a serialized textual representation and employ pretrained foundation models to demonstrate how this enhanced feature representation can aid in antibiotic susceptibility predictions. Our results suggest that this text representation, combined with foundation models, provides a valuable tool to increase interpretability and support antibiotic stewardship efforts.

Advancements in neural machinery have led to a wide range of algorithmic solutions for molecular property prediction. Two classes of models in particular have yielded promising results: neural networks applied to computed molecular fingerprints or expert-crafted descriptors, and graph convolutional neural networks that construct a learned molecular representation by operating on the graph structure of the molecule. However, recent literature has yet to clearly determine which of these two methods is superior when generalizing to new chemical space. Furthermore, prior research has rarely examined these new models in industry research settings in comparison to existing employed models. In this paper, we benchmark models extensively on 19 public and 15 proprietary industrial datasets spanning a wide variety of chemical endpoints. In addition, we introduce a graph convolutional model that consistently outperforms models using fixed molecular descriptors as well as previous graph neural architectures on both public and proprietary datasets. Our empirical findings indicate that while approaches based on these representations have yet to reach the level of experimental reproducibility, our proposed model nevertheless offers significant improvements over models currently used in industrial workflows.